-
As you can see from the image below the company has a melanoma drug about ready to submit for on approval and they are working with Roche (Genentech) for the marketing. The skin cancer drug helps sustain life and is an oral medication taken. Daiichi Sankyo is located in Japan and for the...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Tue, Mar 1 2011
Filed under:
Filed under: Medically Related, Pharma/FDA News, Biotech, Cancer, FDA, Oncology, Doctors, Japan, melanoma, Mergers and Acquisitions, Daiichi Sankyo, Plexxikon
-
The studies were carried out and then halted upon finding out that one of the biostatisticians lied about his background. Much of the published information on the trials has now been retracted and now the FDA is looking into the situation to get additional information. Credentials and backgrounds...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Fri, Jan 28 2011
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, healthcare, Cancer, FDA, clinical trials, Duke University, Journals, credentials, Cancer letter, ID
-
Back in September of 2010 he was also names to the Board of another technology company that deals with urology and cancer therapies. Since his tenure at the FDA it sounds like von Eschenbach is returning to his roots with using his expertise in the clinical area of healthcare. BD Former FDA...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Wed, Jan 19 2011
Filed under:
Filed under: Medically Related, Pharma/FDA News, Cancer, FDA, Prostate Cancer, Pharmaceuticals, National Cancer Institute, enzymes, Durham, Viamet Pharmaceuticals, drug discovery, Andrew von Eschenbach
-
REMS programs are required by the FDA for certain marketed drugs to ensure the benefits of a product offered to consumers outweigh the risks . They can include elements to ensure safe use, communications plans and medication guides, which all require assessment. Just a few months ago, another REMS...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Mon, Jan 10 2011
Filed under:
Filed under: Medically Related, Pharma/FDA News, Pharma, Cancer, FDA, Pain Relief, REMS, risk evalaution and mitigation strategy, addictive drugs, ProStraken), Abstral, register
-
Last year at this time, Varian was not a real popular name due to the over exposure of radiation associated with their units and with the FDA approval I might guess that software certification was probably even more stringent at the FDA before approval was given, or at least it should have been. ...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Mon, Jan 10 2011
Filed under:
Filed under: Medically Related, Technology, Education, Cancer, FDA, Heatlh IT, software, Heatlhcare, Safety, Algorithms, New York, Treatment plans, Varian System, accountability, radation treatment
-
This drug could be used to where other late stage drugs have not been helpful therapies and the drug does extend overall survival for patients. BD MONDAY, Nov. 15 (HealthDay News) -- Halaven (eribulin mesylate) has been approved by the U.S. Food and Drug Administration to treat metastatic...
-
I had the opportunity to chat with Dr. Erika Schwartz recently about Bio Identical Hormone Therapy last year and today here on Fox she’s again talking about the same issues and there Bio identical drugs can help, FDA approved drugs. Check out the interview and you can see that what we talked about...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Sun, Oct 31 2010
Filed under:
Filed under: Medically Related, Other Items of Interest, My Commentaries, healthcare, Cancer, FDA, Diet, NIH, Harvard, HRT, Oprah, estrogen, wellness, Woman's Heatlh, bio identical hormones, Premarin, Dr. Erika, Erika Schwartz, Women's Health Initiative, hormone replacement, Hot Flash Havoctherapytherapy
-
Lymphedema is localized fluid retention and tissue swelling when the lymphatic system is compromised. It cannot be cured and the new pumps approved by the FDA with the CircuFlow devices can help treat and stimulate the correct amount of fluid to avoid build up and infection. The sleeves release...
-
We have a new growing group of specialty physicians, the International CardiOncology. If you have been reading the news of late you see many stories about the affects of cancer drugs on the heart and the FDA is very much alive in this effort and thus the emergence of a new healthcare community...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Tue, Oct 12 2010
Filed under:
Filed under: Medically Related, Technology, Other Items of Interest, Cardiology, Cancer, FDA, Oncology, heart trouble, Cardioncology, speialties
-
Back in July of 2009 a judge ordered the unsealing of documents relating to how the drug was marketed, etc. Pfizer who now owns Wyeth and all the related issues is disputing the report. DesignWrite, a medical communications company in Princeton, N.J., proposed to Wyeth a two-year plan that would...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Tue, Sep 7 2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, healthcare, Hot Flashes, Cancer, FDA, Wyeth, Personal Health Records, Diet, HRT, estrogen, wellness, Woman's Heatlh, bio identical hormones, Premarin, Dr. Erika, Women's Health Initiative, hormone replacement therapy
-
This is an interesting technology as it uses sound waves to help fight the battle with treating urological cancer. Last year it was announced that he also joined the “think tank” of Newt Gingrich. Von Eschenbach Joins Newt Gingrich’s Think Tank – Add a Tiny Bit of Old Knowledge to a Lot of...
-
The medication is given in a film format the dissolves in your mouth, thus no need for water. The drug is to be used for the prevention of Chemotherapy-induced, Radiotherapy-induced, and Postoperative Nausea and Vomiting. For cancer patients needing treatment from the drug, this could make...
-
If you are a cancer patient being treated with this drug, as of today it will no longer be available without a specific request sent to the FDA. The drug did not work in short and there was the side effect of liver disease related to the product. The drug was used as a treatment for bone...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Mon, Jun 21 2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, Cancer, FDA, Pfizer, Chemotherapy, Side Effects, bone marrow cancer, Mylotarg, liver disease
-
The test is done pre-surgery and is a pre-operative evaluation. Quest Diagnostics has the test and women must have not already been referred to a specialist in oncology. The test if negative results would generate that need I would assume immediately. Ovarian masses are common...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Thu, Jun 3 2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, Labs, healthcare, Cancer, FDA, Blood Tests, ovarian cancer, Quest Diagnostics, womens healthcare, OVA1
-
The judge did reduce the original punitive damages from $99 million and said ok to the $58 million dollar settlement. When you read through the article we are splitting hairs here over which state the case should have been heard in and when and where (which state) were the women living when they...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Tue, May 4 2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, healthcare, Cancer, FDA, Wyeth, Diet, NIH, Harvard, HRT, estrogen, wellness, hormone replacement therapytherapy, bio identical hormones, Premarin, Dr. Erika, Erika Schwartz, Women's Health Initiative